KBI plans $150M facility in Research Triangle Park with mystery co-investor
A month after unveiling plans for a new manufacturing facility in Geneva, KBI Biopharma has already pegged the location for its next site: a $150 million facility in Research Triangle Park, North Carolina.
The 140,000-square-foot facility will be fully operational by Q1 2022, and the contract services company says it will be home to more than 200 operations and quality assurance staffers. A mystery partner is chipping in on the facility to manufacture its protein therapies, though KBI is keeping mum about who.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.